As jurisdictions around the world legalize or decriminalize recreational drugs, interest is growing in their therapeutic value. Magic mushrooms, for example, are gaining traction as a treatment for certain mental illnesses, like anxiety and depression.

We speak with Dr. Peter Facchini, a professor of biochemistry in our Faculty of Science and chief scientific officer of MagicMed, about studying the medicinal properties of psilocybin mushrooms and other drugs, and how synthesizing and improving them could lead to better mental health treatments.

Have an idea for a future episode or questions you'd like answered? Email [email protected].